• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Jazz Pharma and Sumitomo Pharma to develop therapies for sleep disorders

cafead

Administrator
Staff member
  • cafead   May 05, 2022 at 10:32: AM
via Jazz Pharmaceuticals and Sumitomo Pharma partner to develop and commercialize DSP-0187, a potent, highly selective oral orexin-2 receptor agonist

article source